BamSEC and AlphaSense Join Forces
Learn More

Provention Bio Inc

Formerly NASDAQ: PRVB
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.29
from 10-K 4 pages Certain Portions of This Exhibit (Indicated by [***]) Have Been Excluded Pursuant to Item 601(b)(10) of Regulation S-K Because They Are Both Not Material and Are the Type That the Company Treats as Private and Confidential. Amendment No. 1 to Asset Purchase Agreement
12/34/56
EX-10.2
from 8-K/A 23 pages Certain Confidential Information Contained in This Document, Marked With [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K/A 60 pages Certain Confidential Information Contained in This Document, Marked With [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Co-Promotion Agreement by and Between Provention Bio, Inc. and Genzyme Corporation Dated as of October 4, 2022
12/34/56
EX-10.6
from 8-K 4 pages Eleanor Ramos March 12, 2023 Dear Eleanor
12/34/56
EX-10.5
from 8-K 4 pages Thierry Chauche March 12, 2023 Dear Thierry
12/34/56
EX-10.4
from 8-K 4 pages Ashleigh Palmer March 12, 2023 Dear Ashleigh
12/34/56
EX-10.3
from 8-K 2 pages Second Amendment to First Amended Employment Agreement
12/34/56
EX-10.2
from 8-K 2 pages Second Amendment to Employment Agreement
12/34/56
EX-10.1
from 8-K 2 pages Second Amendment to First Amended Employment Agreement
12/34/56
EX-10.5
from 10-Q 3 pages Amendment to Employment Agreement
12/34/56
EX-10.4
from 10-Q 3 pages Amendment to Employment Agreement
12/34/56
EX-10.3
from 10-Q 3 pages Amendment to Employment Agreement
12/34/56
EX-10.1
from 10-Q 59 pages Agreement
12/34/56
EX-10.1
from 8-K 37 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 5 pages Provention Bio, Inc. Scientific Advisor Agreement
12/34/56
EX-10.1
from 8-K 17 pages Provention Bio, Inc. 2020 Inducement Plan, as Amended Adopted: October 29, 2020 Amended: May 17, 2022
12/34/56
EX-10.23
from 10-K 16 pages Employment Agreement
12/34/56
EX-10.22
from 10-K 7 pages November 1, 2021 via Email Andrew Drechsler Dear Andy: This Letter Agreement (This “Agreement”) Confirms the Terms of the Remainder of Your Employment With Provention Bio, Inc. (The “Company”) and Your Engagement as a Consultant by the Company, as Follows: 1. Transition Period
12/34/56
EX-10.1
from 10-Q 5 pages Provention Bio, Inc. Stock Option Grant Agreement
12/34/56
EX-10.1
from 10-Q 15 pages Employment Agreement
12/34/56